Literature DB >> 7169514

Maternal serum hormone changes during abortion induced with 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2.

K Bremme, P Eneroth, M Bygdeman.   

Abstract

Serum hormone levels in women undergoing successful first and second trimester abortions induced by 9-deoxo-16, 16-dimethyl-9-methylene prostaglandin E2 vagitories have been measured. Significantly decreased levels of prolactin (p less than 0.01) and TSH (p less than 0.05) were seen in both groups of women but the drop appeared sooner, within two hours, in first trimester abortions. Regardless of gestational length there was a significant decrease in serum human chorionic gonadotropin (hCG) (p less than 0.01) concentrations in maternal serum six hours into treatment. In the second trimester abortions total estriol, alpha-fetoprotein and lactoplacental hormone hPL were analysed in maternal serum but the levels did not change over the eight hour investigation period. It is speculated that the PGE2-derivative most likely affects the maternal pituitary secretion of prolactin and TSH, possibly via direct or indirect interference with TRH mechanism(s).

Entities:  

Keywords:  Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Age Factors; Alpha Fetoproteins--analysis; Biology; Blood Proteins; Endocrine System; Estriol--analysis; Estrogens; Family Planning; Fertility Control, Postconception; Gonadotropins; Gonadotropins, Chorionic--analysis; Gonadotropins, Pituitary; Hemic System; Hormones; Parity; Physiology; Pituitary Hormones; Pregnancy; Pregnancy, First Trimester; Pregnancy, Second Trimester; Prolactin--analysis; Prostaglandins--administraction and dosage; Reproduction

Mesh:

Substances:

Year:  1982        PMID: 7169514     DOI: 10.1007/bf03350538

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Prolactin and human placental lactogen changes in maternal serum and amniotic fluid in midtrimester induced abortions.

Authors:  R R Weiss; A G Frantz; J N Macri; J Robins; J G Merker
Journal:  Am J Obstet Gynecol       Date:  1977-09-01       Impact factor: 8.661

2.  Effect of prostaglandin F2 alpha on the secretion of human prolactin.

Authors:  D K Yue; I D Smith; J R Turtle; R P Shearman
Journal:  Prostaglandins       Date:  1974-12-10

3.  Second trimester termination by intra-uterine prostaglandin F 2 . Clinical and hormonal results with observations on induced lactation and chronoperiodicity.

Authors:  R Shearman; I Smith; A Korda
Journal:  J Reprod Med       Date:  1972-12       Impact factor: 0.142

4.  New prostaglandin E2 analogue for pregnancy termination.

Authors:  M Bygdeman; K Gréen; S Bergström; G Bundy; F Kimball
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321

5.  Sources and disposition of pituitary prolactin in maternal circulation, amniotic fluid, fetus and placenta in the pregnant rhesus monkey.

Authors:  J B Josimovich; G Weiss; D L Hutchinson
Journal:  Endocrinology       Date:  1974-05       Impact factor: 4.736

6.  Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro.

Authors:  A Golander; J Barrett; T Hurley; S Barry; S Handwerger
Journal:  J Clin Endocrinol Metab       Date:  1979-11       Impact factor: 5.958

7.  First-trimester serum prolactin levels in normal and complicated pregnancies.

Authors:  P Riss; R Mick; J Spona
Journal:  Gynecol Obstet Invest       Date:  1980       Impact factor: 2.031

8.  Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy.

Authors:  W D Lehmann; K Musch; A S Wolf
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

9.  Treatment with a single vaginal suppository containing 15-methyl PGF2 alpha methyl ester at expected time of menstruation.

Authors:  K Kinoshita; P Eneroth; M Bygdeman
Journal:  Prostaglandins       Date:  1979-03

10.  Multiphasic prolactin secretion during parturition in human subjects.

Authors:  L A Rigg; S S Yen
Journal:  Am J Obstet Gynecol       Date:  1977-05-15       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.